Locally Advanced/Metastatic HER2 Positive Solid Tumors
1 clinical trials · Condition
◉ Watch Locally Advanced/Metastatic HER2 Positive Solid Tumors
| Record | Firm | Date |
|---|---|---|
| A First-in-human Study of Multiple Doses of BB-1701 in Subjects With Locally Advanced/Metastatic HER2 Expressing Solid Tumors (NCT04257110) | Bliss Biopharmaceutical (Hangzhou) Co., Ltd | 2020-07-28 |
Track Locally Advanced/Metastatic HER2 Positive Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.